VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockadeJohn S. Rudge, George D. Yancopoulos, Donna Hylton et al.|Proceedings of the National Academy of Sciences|2007Cited by 203
Aflibercept exhibits VEGF binding stoichiometry distinct from bevacizumab and does not support formation of immune-like complexesDouglas MacDonald, Nicholas Papadopoulos|Angiogenesis|2016Cited by 44